文献速递心胸血管麻醉

体外循环后鱼精蛋白给药策略比较:固定剂量与比例剂量随机对照试验

Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies.
PubMed 文献 · Anesthesiology · 2025-01-01

两组初始鱼精蛋白后活化凝血时间无差异(-2.0 s,95%CI -7.2至3.3 s,P=0.47),固定剂量组总鱼精蛋白用量更少,24小时胸腔引流量无差异。

要点

  • 固定250 mg鱼精蛋白与1:1比例给药相比,初始活化凝血时间无显著差异
  • 固定剂量组总鱼精蛋白用量显著减少(-2.1瓶50 mg,95%CI -2.4至-1.8,P<0.0001)
  • 两组24小时胸腔引流量无差异(-77 ml,95%CI -220至65 ml,P=0.28)

核心结论

  • 与固定250 mg剂量相比,1:1肝素比例鱼精蛋白给药策略导致总鱼精蛋白用量更大,但初始活化凝血时间和术后胸腔引流量均无差异。

研究设计与样本

  • 单中心双盲前瞻性随机对照试验,纳入择期成人心脏手术患者,无预先存在的凝血病或持续抗凝,计算初始肝素剂量≥27,500 U,随机分为固定剂量组(250 mg)和比例剂量组(1 mg:100 U肝素),固定剂量组62例,比例剂量组63例。

主要发现

  • 初始鱼精蛋白后平均活化凝血时间组间无差异(-2.0 s;95%CI -7.2至3.3 s;P=0.47)。
  • 固定剂量组每例总鱼精蛋白用量更少(-2.1瓶50 mg;95%CI -2.4至-1.8;P<0.0001)。
  • 累计24小时胸腔引流量无差异(差值-77 ml;95%CI -220至65 ml;P=0.28)。

临床怎么用

  • 在符合条件的成人心脏手术患者中,体外循环后可采用固定250 mg鱼精蛋白进行肝素逆转,以减少鱼精蛋白总用量,同时不增加初始活化凝血时间或术后出血。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Drug shortages are a frequent challenge in current clinical practice. Certain drugs (e.g., protamine) lack alternatives, and inadequate supplies can limit access to services. Conventional protamine dosing uses heparin ratio-based calculations for heparin reversal after cardiopulmonary bypass and may result in excess protamine utilization and potential harm due to its intrinsic anticoagulation. This study hypothesized that a fixed 250-mg protamine dose would be comparable, as measured by the activated clotting time, to a 1:1 (1 mg for every 100 U) protamine-to-heparin ratio-based strategy for heparin reversal and that protamine would be conserved. METHODS: In a single-center, double-blinded trial, consenting elective adult cardiac surgical patients without preexisting coagulopathy or ongoing anticoagulation and a calculated initial heparin dose greater than or equal to 27,500 U were randomized to receive, after cardiopulmonary bypass, protamine as a fixed dose (250 mg) or a ratio-based dose (1 mg:100 U heparin). The primary outcome was the activated clotting time after initial protamine administration, assessed by Student's t test. Secondary outcomes included total protamine, the need for additional protamine, and the cumulative 24-h chest tube output. RESULTS: There were 62 and 63 patients in the fixed- and ratio-based dose groups, respectively. The mean postprotamine activated clotting time was not different between groups (-2.0 s; 95% CI, -7.2 to 3.3 s; P = 0.47). Less total protamine per case was administered in the fixed-dose group (-2.1 50-mg vials; 95% CI, -2.4 to -1.8; P < 0.0001). There was no difference in the cumulative 24-h chest tube output (difference, -77 ml; 95% CI, 220 to 65 ml; P = 0.28). CONCLUSIONS: A 1:1 heparin ratio-based protamine dosing strategy compared to a fixed 250-mg dose resulted in the administration of a larger total dose of protamine but no difference in either the initial activated clotting time or the amount postoperative chest-tube bleeding.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Jain P, Silva-De Las Salas A, Bedi K, et al. Protamine Dosing for Heparin Reversal after Cardiopulmonary Bypass: A Double-blinded Prospective Randomized Control Trial Comparing Two Strategies. Anesthesiology. 2025. PMID: 39388600. doi:10.1097/ALN.0000000000005256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。